Direct answer: Insurers usually want a prior-authorization form, chart notes, diagnosis details, BMI data, and a clear reason the medication is medically appropriate
In new data presented at the American Diabetes Association Scientific Sessions, a subanalysis showed the reduced risks observed in FLOWs main analysis did not differ between BMI subgroups and were independent of change in body weight
Final thoughts Tesofensine represents a powerful weight loss compound with proven 10-12% average weight loss through triple monoamine reuptake inhibition targeting dopamine, norepinephrine, and serotonin
The right choice is personal and worth discussing with your doctor
Eating a balanced GLP-1 meal plan helps ensure your body still gets the essential vitamins and nutrients it needs, rather than relying on empty calories that offer little nutritional value